Trial Details
RecruitingBasic Information
| Clinical ID | c2091 |
|---|---|
| Identifier | NCT06351124 |
| Trial Title | Feasibility of Beta-hydroxybutyrate Supplementation to Reduce Inflammation in Patients with Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's Disease;Inflammatory Bowel Diseases |
| Interventions | Biological: Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's |
Participant Information
| Sponsor | University of Texas at Austin |
|---|---|
| City | - |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |